The Smartest Biotech Stocks to Buy With $50
One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that perform well tend to attract plenty of attention that bids up their share prices, it's possible to buy shares of quality stocks with $50 -- or less.Here are two great examples in the biotech industry: Viking Therapeutics (NASDAQ: VKTX) and Exelixis (NASDAQ: EXEL). These two drugmakers could generate outsized returns to investors who initiate positions now.Viking Therapeutics, a mid-cap biotech, is looking to make waves in the fast-growing market for weight management medicines. Last year, it reported positive phase 2 results for the subcutaneous formulation of its leading candidate, VK2735. It will move forward with phase 3 studies for this product soon. Meanwhile, Viking Therapeutics is also developing an oral version of its anti-obesity therapy; this formulation recently started phase 2 studies after performing well in a phase 1 clinical trial last year.Continue reading
One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that perform well tend to attract plenty of attention that bids up their share prices, it's possible to buy shares of quality stocks with $50 -- or less.
Here are two great examples in the biotech industry: Viking Therapeutics (NASDAQ: VKTX) and Exelixis (NASDAQ: EXEL). These two drugmakers could generate outsized returns to investors who initiate positions now.
Viking Therapeutics, a mid-cap biotech, is looking to make waves in the fast-growing market for weight management medicines. Last year, it reported positive phase 2 results for the subcutaneous formulation of its leading candidate, VK2735. It will move forward with phase 3 studies for this product soon. Meanwhile, Viking Therapeutics is also developing an oral version of its anti-obesity therapy; this formulation recently started phase 2 studies after performing well in a phase 1 clinical trial last year.
